Patents by Inventor Shaji Daniel

Shaji Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260265394
    Abstract: Provided herein are proteins that comprise a CD3-zeta intracellular domain, such as Chimeric Antigen Receptors (CARs), such as those specific for BCMA, that have improved properties. Use of the proteins that comprise a CD3-zeta intracellular domain, such as CARs, in immune cells (e.g., T cells), compositions (e.g., CARs and nucleic acid constructs encoding the same), and methods are also contemplated.
    Type: Application
    Filed: March 15, 2024
    Publication date: September 10, 2026
    Applicant: Cartesian Therapeutics, Inc.
    Inventors: Yi Zhang, Shaji Daniel, Atsuo Ochi, C. Andrew Stewart, Metin Kurtoglu, Murat V. Kalayoglu, Michael S. Singer
  • Patent number: 12709739
    Abstract: Provided herein are mammalian cells comprising a first exogenous nucleic acid encoding a DNAse protein and a second exogenous nucleic acid encoding another DNAse protein, such as DNASE1 protein and DNASE1L3 protein, that have improved properties, including the ability to degrades extracellular chromatin and remove Neutrophil Extracellular Traps (NETs). Use of these cells, including the use in the treatment of a subject in need thereof, is also contemplated.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: August 18, 2026
    Assignee: Cartesian Therapeutics, Inc.
    Inventors: Yi Zhang, C. Andrew Stewart, Shaji Daniel, Metin Kurtoglu, Murat V. Kalayoglu
  • Publication number: 20230174944
    Abstract: Provided herein are mammalian cells comprising a first exogenous nucleic acid encoding a DNAse protein and a second exogenous nucleic acid encoding another DNAse protein, such as DNASE1 protein and DNASE1L3 protein, that have improved properties, including the ability to degrades extracellular chromatin and remove Neutrophil Extracellular Traps (NETs). Use of these cells, including the use in the treatment of a subject in need thereof, is also contemplated.
    Type: Application
    Filed: April 15, 2021
    Publication date: June 8, 2023
    Applicant: Cartesian Therapeutics, Inc.
    Inventors: Yi Zhang, C. Andrew Stewart, Shaji Daniel, Metin Kurtoglu, Murat V. Kalayoglu